Asia-Pacific Bevacizumab Biosimilar Market Analysis 2012-2017 and Forecast 2018-2023

April 2018 | 106 pages | ID: AE4128BF207EN
99Strategy

Abstracts

SNAPSHOT

The Asia-Pacific Bevacizumab Biosimilar market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Bevacizumab Biosimilar by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• 100mg
• 400mg

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• Pfizer
• Allergan
• Amgen
• Biocon
• Reliance lifesciences
• Bevacizumab
• Beaconpharma
• Celgene Corporation
• Fujifilm Kyowa Kirin Biologics
• Hetero Drugs

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Colorectal Cancer
• Lung Cancer
• Breast Cancer
• Renal Cancer
• Brain Cancer
• Others

Region Coverage (Regional Production, Demand & Forecast by Regions etc.):

• China
• Japan & Korea
• India
• Southeast Asia
• Oceania

Contents

1 INDUSTRY OVERVIEW

1.1 Bevacizumab Biosimilar Industry
  1.1.1 Overview
  1.1.2 Development of Bevacizumab Biosimilar
1.2 Market Segment
  1.2.1 By Product Type
  1.2.2 By Application
1.3 Asia-Pacific Overview

2 MAJOR COMPANIES LIST

2.1 Pfizer (Company Profile, Products & Services, Sales Data etc.)
2.2 Allergan (Company Profile, Products & Services, Sales Data etc.)
2.3 Amgen (Company Profile, Products & Services, Sales Data etc.)
2.4 Biocon (Company Profile, Products & Services, Sales Data etc.)
2.5 Reliance lifesciences (Company Profile, Products & Services, Sales Data etc.)
2.6 Bevacizumab (Company Profile, Products & Services, Sales Data etc.)
2.7 Beaconpharma (Company Profile, Products & Services, Sales Data etc.)
2.8 Celgene Corporation (Company Profile, Products & Services, Sales Data etc.)
2.9 Fujifilm Kyowa Kirin Biologics (Company Profile, Products & Services, Sales Data etc.)
2.10 Hetero Drugs (Company Profile, Products & Services, Sales Data etc.)

3 MARKET COMPETITION

3.1 Company Competition
3.2 Regional Market by Company

4 BEVACIZUMAB BIOSIMILAR MARKET BY TYPE

4.1 By Type
  4.1.1 100mg
  4.1.2 400mg
4.2 Market Size
4.3 Market Forecast

5 MARKET DEMAND

5.1 Demand Situation
  5.1.1 Demand in Colorectal Cancer
  5.1.2 Demand in Lung Cancer
  5.1.3 Demand in Breast Cancer
  5.1.4 Demand in Renal Cancer
  5.1.5 Demand in Brain Cancer
  5.1.6 Demand in Others
5.2 Regional Demand Comparison
5.3 Demand Forecast

6 REGION OPERATION

6.1 Regional Production
6.2 Regional Market
6.3 by Region
  6.3.1 China
    6.3.1.1 By Type
    6.3.1.2 By Application
  6.3.2 Japan & Korea
    6.3.2.1 By Type
    6.3.2.2 By Application
  6.3.3 India
    6.3.3.1 By Type
    6.3.3.2 By Application
  6.3.4 Southeast Asia
    6.3.4.1 By Type
    6.3.4.2 By Application
  6.3.5 Oceania
    6.3.5.1 By Type
    6.3.5.2 By Application
6.4 Regional Forecast

7 MARKETING & PRICE

7.1 Price and Margin
  7.1.1 Price Trends
  7.1.2 Factors of Price Change
  7.1.3 Manufacturers Gross Margin Analysis
7.2 Marketing Channel

8 UPSTREAM & COST

8.1 Upstream
8.2 Cost

9 INDUSTRY ENVIRONMENT

9.1 Policy
9.2 Economics
9.3 Sociology
9.4 Technology

10 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Product Segment of Bevacizumab Biosimilar
Table Asia-Pacific Bevacizumab Biosimilar Market 2012-2023, by Product Type, in USD Million
Table Application Segment of Bevacizumab Biosimilar
Table Asia-Pacific Bevacizumab Biosimilar Market 2012-2023, by Application, in USD Million
Table Pfizer Overview List
Table Bevacizumab Biosimilar Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Overview List
Table Bevacizumab Biosimilar Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Bevacizumab Biosimilar Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biocon Overview List
Table Bevacizumab Biosimilar Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Reliance lifesciences Overview List
Table Bevacizumab Biosimilar Business Operation of Reliance lifesciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bevacizumab Overview List
Table Bevacizumab Biosimilar Business Operation of Bevacizumab (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Beaconpharma Overview List
Table Bevacizumab Biosimilar Business Operation of Beaconpharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Bevacizumab Biosimilar Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fujifilm Kyowa Kirin Biologics Overview List
Table Bevacizumab Biosimilar Business Operation of Fujifilm Kyowa Kirin Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hetero Drugs Overview List
Table Bevacizumab Biosimilar Business Operation of Hetero Drugs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Asia-Pacific Bevacizumab Biosimilar Sales Revenue 2012-2017, by Company, in USD Million
Table Asia-Pacific Bevacizumab Biosimilar Sales Revenue Share, by Company, in USD Million
Table Asia-Pacific Bevacizumab Biosimilar Sales Volume 2012-2017, by Company, in Volume
Table Asia-Pacific Bevacizumab Biosimilar Sales Volume Share 2012-2017, by Company, in Volume
Table Major Company List of 100mg
Table Major Company List of 400mg
Table Asia-Pacific Bevacizumab Biosimilar Market 2012-2017, by Type, in USD Million
Table Asia-Pacific Bevacizumab Biosimilar Market 2012-2017, by Type, in Volume
Table Asia-Pacific Bevacizumab Biosimilar Market Forecast 2018-2023, by Type, in USD Million
Table Asia-Pacific Bevacizumab Biosimilar Market Forecast 2018-2023, by Type, in Volume
Table Bevacizumab Biosimilar Demand in Colorectal Cancer, 2012-2017, in USD Million
Table Bevacizumab Biosimilar Demand in Colorectal Cancer, 2012-2017, in Volume
Table Major Consumers in Colorectal Cancer
Table Bevacizumab Biosimilar Demand in Lung Cancer, 2012-2017, in USD Million
Table Bevacizumab Biosimilar Demand in Lung Cancer, 2012-2017, in Volume
Table Major Consumers in Lung Cancer
Table Bevacizumab Biosimilar Demand in Breast Cancer, 2012-2017, in USD Million
Table Bevacizumab Biosimilar Demand in Breast Cancer, 2012-2017, in Volume
Table Major Consumers in Breast Cancer
Table Bevacizumab Biosimilar Demand in Renal Cancer, 2012-2017, in USD Million
Table Bevacizumab Biosimilar Demand in Renal Cancer, 2012-2017, in Volume
Table Major Consumers in Renal Cancer
Table Bevacizumab Biosimilar Demand in Brain Cancer, 2012-2017, in USD Million
Table Bevacizumab Biosimilar Demand in Brain Cancer, 2012-2017, in Volume
Table Major Consumers in Brain Cancer
Table Bevacizumab Biosimilar Demand in Others, 2012-2017, in USD Million
Table Bevacizumab Biosimilar Demand in Others, 2012-2017, in Volume
Table Major Consumers in Others
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Bevacizumab Biosimilar Demand Forecast 2018-2023, by Application, in USD Million
Table Bevacizumab Biosimilar Demand Forecast 2018-2023, by Application, in Volume
Table Bevacizumab Biosimilar Production 2012-2017, by Region, in USD Million
Table Bevacizumab Biosimilar Production 2012-2017, by Region, in Volume
Table Asia-Pacific Bevacizumab Biosimilar Market Size 2012-2017, by Region, in USD Million
Table Asia-Pacific Bevacizumab Biosimilar Market Size 2012-2017, by Region, in Volume
Table China Bevacizumab Biosimilar Market Size 2012-2017, by Type, in USD Million
Table China Bevacizumab Biosimilar Market Size 2012-2017, by Type, in Volume
Table China Bevacizumab Biosimilar Market Size 2012-2017, by Application, in USD Million
Table China Bevacizumab Biosimilar Market Size 2012-2017, by Application, in Volume
Table Japan & Korea Bevacizumab Biosimilar Market Size 2012-2017, by Country, in USD Million
Table Japan & Korea Bevacizumab Biosimilar Market Size 2012-2017, by Country, in Volume
Table Japan Bevacizumab Biosimilar Market Size 2012-2017, by Type, in USD Million
Table Japan Bevacizumab Biosimilar Market Size 2012-2017, by Type, in Volume
Table Japan Bevacizumab Biosimilar Market Size 2012-2017, by Application, in USD Million
Table Japan Bevacizumab Biosimilar Market Size 2012-2017, by Application, in Volume
Table India Bevacizumab Biosimilar Market Size 2012-2017, by Country, in USD Million
Table India Bevacizumab Biosimilar Market Size 2012-2017, by Country, in Volume
Table India Bevacizumab Biosimilar Market Size 2012-2017, by Type, in USD Million
Table India Bevacizumab Biosimilar Market Size 2012-2017, by Type, in Volume
Table India Bevacizumab Biosimilar Market Size 2012-2017, by Application, in USD Million
Table India Bevacizumab Biosimilar Market Size 2012-2017, by Application, in Volume
Table Southeast Asia Bevacizumab Biosimilar Market Size 2012-2017, by Country, in USD Million
Table Southeast Asia Bevacizumab Biosimilar Market Size 2012-2017, by Country, in Volume
Table Southeast Asia Bevacizumab Biosimilar Market Size 2012-2017, by Type, in USD Million
Table Southeast Asia Bevacizumab Biosimilar Market Size 2012-2017, by Type, in Volume
Table Southeast Asia Bevacizumab Biosimilar Market Size 2012-2017, by Application, in USD Million
Table Southeast Asia Bevacizumab Biosimilar Market Size 2012-2017, by Application, in Volume
Table Oceania Bevacizumab Biosimilar Market Size 2012-2017, by Country, in USD Million
Table Oceania Bevacizumab Biosimilar Market Size 2012-2017, by Country, in Volume
Table Oceania Bevacizumab Biosimilar Market Size 2012-2017, by Type, in USD Million
Table Oceania Bevacizumab Biosimilar Market Size 2012-2017, by Type, in Volume
Table Oceania Bevacizumab Biosimilar Market Size 2012-2017, by Application, in USD Million
Table Oceania Bevacizumab Biosimilar Market Size 2012-2017, by Application, in Volume
Table Bevacizumab Biosimilar Market Forecast 2018-2023, by Region, in USD Million
Table Bevacizumab Biosimilar Market Forecast 2018-2023, by Region, in Volume
Table Price Factors List
Table Upstream Segment of Bevacizumab Biosimilar

List Of Figures

LIST OF FIGURES

Figure Bevacizumab Biosimilar Industry Chain Structure
Figure Asia-Pacific Bevacizumab Biosimilar Market Size and Growth Rate 2012-2023
Figure China Bevacizumab Biosimilar Market, by Company, in 2018
Figure Japan & Korea Bevacizumab Biosimilar Market, by Company, in 2018
Figure India Bevacizumab Biosimilar Market, by Company, in 2018
Figure Southeast Asia Bevacizumab Biosimilar Market, by Company, in 2018
Figure Oceania Bevacizumab Biosimilar Market, by Company, in 2018
Figure Asia-Pacific Bevacizumab Biosimilar Market Growth 2012-2017, by Type, in USD Million
Figure Asia-Pacific Bevacizumab Biosimilar Market Growth 2012-2017, by Type, in Volume
Figure China Bevacizumab Biosimilar Market Size and Growth 2012-2017, in USD Million
Figure China Bevacizumab Biosimilar Market Size and Growth 2012-2017, in Volume
Figure Japan & Korea Bevacizumab Biosimilar Market Size and Growth 2012-2017, in USD Million
Figure Japan & Korea Bevacizumab Biosimilar Market Size and Growth 2012-2017, in Volume
Figure India Bevacizumab Biosimilar Market Size and Growth 2012-2017, in USD Million
Figure India Bevacizumab Biosimilar Market Size and Growth 2012-2017, in Volume
Figure Southeast Asia Bevacizumab Biosimilar Market Size and Growth 2012-2017, in USD Million
Figure Southeast Asia Bevacizumab Biosimilar Market Size and Growth 2012-2017, in Volume
Figure Oceania Bevacizumab Biosimilar Market Size and Growth 2012-2017, in USD Million
Figure Oceania Bevacizumab Biosimilar Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview